Company / Tangible Book Value per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$7.23
FY2025
5-year range
-$8.81 / -$6.74
FY2021-FY2025
Trend
+17.9%
vs FY2024
Sector context
#204 of 209
Health Care
What the data says
Among 209 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the bottom 2% for tangible book value per share. Tangible Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $-7.23.
Based on SEC 10-K filings.
-7.23 in FY2025.
Improved from $-8.74 to $-7.23 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 209This company -$7.23 Sector average $119.74
▼
-106.0% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 17.9% year-over-year.
- Ranks #204 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.23 | +17.9% |
| FY2024 | -$8.81 | -0.8% |
| FY2023 | -$8.74 | -2.1% |
| FY2022 | -$8.56 | -27.0% |
| FY2021 | -$6.74 | +35.1% |
| FY2020 | -$10.38 | +3.0% |
| FY2019 | -$10.70 | +100.0% |
| FY2018 | -$10624349.64 | -111638531.0% |
| FY2017 | -$9.52 | +100.0% |
| FY2016 | -$9798126.95 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026